Rafinlar 50mg Capsule
Product introduction
Rafinlar 50mg Capsule should be taken at least 1 hour before or 2 hours after a meal in the dose as advised by the doctor. The duration of treatment varies on the basis of your response to the treatment. Your doctor may advice regular eye examinations while taking this medicine. You must inform the doctor if you experience eye irritation, blurred vision, eye pain, or other vision changes during your treatment.
The most common side effects of this medicine include diarrhea, fever, nausea, and headache. If they do not go away or get worse, tell your doctor. There may be ways of preventing or reducing these effects. It is very strong medicine and some people may develop serious side effects while taking it. It may lower your ability to fight infections and lead to problems with your blood, liver, or kidneys. Inform your doctor if you notice unusual bleeding or bruising, lack of energy, loss of appetite, and yellowing of eyes. Your doctor will advise you regular blood tests to check for these.
Before taking Rafinlar 50mg Capsule, tell your doctor if you have liver or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine, so let your doctor know about all the medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during the treatment with this drug is important to avoid pregnancy.
Uses of Rafinlar Capsule
Benefits of Rafinlar Capsule
In Treatment of Malignant melanoma
Side effects of Rafinlar Capsule
Common side effects of Rafinlar
- Diarrhea
- Fever
- Nausea
- Chills
- Headache
- Joint pain
- Cough
- Muscle pain
- Swelling
How to use Rafinlar Capsule
How Rafinlar Capsule works
Safety advice
All substitutes
Quick tips
- Rafinlar 50mg Capsule is used alone or in combination with other medicines to treat a type of skin cancer called melanoma.
- Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.
- Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for 4 months after you stop taking it.
- Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Get regular eye examinations while taking this medicine. Inform your doctor if you get eye irritation, blurred vision, eye pain or other vision changes during your treatment.
- Inform your doctor if you develop symptoms of liver damage such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
- Rafinlar 50mg Capsule is used alone or in combination with other medicines to treat a type of skin cancer called melanoma.
- Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.
- Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for 4 months after you stop taking it.
- Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Get regular eye examinations while taking this medicine. Inform your doctor if you get eye irritation, blurred vision, eye pain or other vision changes during your treatment.
- Inform your doctor if you develop symptoms of liver damage such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
Fact Box
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Dabrafenib mesilate. Surrey, UK: Novartis Europharm Limited; 2013 [revised 20 Feb. 2019]. [Accessed 26 Mar. 2019] (online) Available from:
- Dabrafenib. East Hanover, New Jersey: Novartis Pharmaceuticals; 2013 [revised Jun. 2017]. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Lab tests offered by us
